Recombinant Mouse Tnf, None tagged

  • Check with publisher
  • Published date: February 26, 2019
  • Modified date: September 21, 2019
    • Shirley, New York

Cat.No.: Tnf-484M
Product Overview: Recombinant Mouse Tnf (NP_038721.1) soluble form (Leu 80-Leu 235), fused with an initial Met at the C-terminus, was produced in E. coli.
Source: E. coli
Species: Mouse
Form: Lyophilized from sterile 50mM Tris 0.2M NaCl, pH 7.2
Molecular Mass: The recombinant mouse TNF-α consists of 157 amino acids and migrates with an apparent molecular mass of 17 kDa as estimated in SDS-PAGE under reducing conditions.
https://www.creativebiomart.net/description_9487_12.htm

Result 0 votes
Caroline Green
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • ZSCAN4 peptide

    ZSCAN4 peptide

    Pharmacology - Drug Development Shirley (New York) February 22, 2019 Check with publisher

    The ZSCAN4 gene encodes a protein involved in telomere maintenance and with a key role in the critical feature of mouse embryonic stem (ES) cells, namely, defying cellular senescence and maintaining normal karyotype for many cell divisions in culture...

  • Wnt1 peptide

    Wnt1 peptide

    Pharmacology - Drug Development Shirley (New York) February 22, 2019 Check with publisher

    The WNT gene family consists of structurally related genes which encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during em...

  • Fully Synthetic Carbohydrate Based Cancer Vaccines

    Fully Synthetic Carbohydrate Based Cancer Vaccines

    Pharmacology - Drug Development Shirley (New York) January 28, 2019 Check with publisher

    Malignantly transformed cells often exhibit aberrant levels and types of cell surface carbohydrates, which are typically displayed as either glycoproteins or glycosphingolipids. Through exposure of the immune system to appropriately presented tumor a...